Welcome back to AI 411, a monthly roundup of artificial intelligence (AI) announcements from across the healthcare industry.
Last month, we wrote about the release of Elsa, an FDA AI tool designed to summarize events and assist with safety profile assessments, label comparisons, and code for nonclinical databases. This month, news emerged that Elsa is already hallucinating studies that were never conducted, and FDA employees told CNN the tool is “unreliable.”
But wait, there’s more. Here’s your roundup of health-related AI updates from around the industry.
Abridge. Abridge, known for its AI scribe, announced on July 24 a new collaboration with New York’s Hospital for Special Surgery, named the best hospital for orthopedics in 2025–2026 by US News & World Report. Abridge’s AI platform will be used on approximately 200,000 patients yearly at the hospital to take notes for clinicians.
Aidoc. On July 23, health tech Aidoc announced a $150 million investment that will fund development of Care, its AI model that supports clinical decision-making. Investment was led by venture capitalists (VCs) General Catalyst and Square Peg, with additional participation from Nvidia’s VC arm, NVentures, and health systems including Connecticut’s Hartford HealthCare, Chicago’s Mercy, Sacramento’s Sutter Health, and WellSpan Health in York, Pennsylvania. The company said its total funding has hit $370 million.
Ambience. Another company with AI documentation technology, Ambience, shared July 29 it raised $243 million in Series C funding to improve its platform, which is already in use at Cleveland Clinic, UCSF Health, Houston Methodist, and more. Funding was co-led by VCs Oak HC/FT and Andreessen Horowitz. The company’s valuation is now $1.3 billion, according to Stat.
Navigate the healthcare industry
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
Doximity. On July 24, Doximity launched a free AI scribe tool for all “verified US physicians, NPs, PAs, and medical students” to allow for wider access to clinical documentation technology.
Evidently. Evidently, which has an AI-driven clinical data intelligence platform, announced on July 8 a partnership with Minnesota-based health system Allina Health. Evidently’s platform will process patient encounters using AI summarization and documentation tools to lighten clinicians’ workloads.
Nvidia. Rochester, Minnesota-based health system Mayo Clinic deployed Nvidia Blackwell on July 28, establishing an “advanced computing infrastructure” that can drive model development for pathomics, drug discovery, and precision medicine to improve patient care quality.
Plexision. Pittsburgh-based biotech Pelxision shared on July 24 it has gained a $365,000 investment from the nonprofit Richard King Mellon Foundation to accelerate AI and machine learning capabilities into its cell-based blood tests. The company’s goal is to improve predictive accuracy for transplant outcomes.
Ryght AI. Startup Ryght AI, which automates clinical trials using digital twins, announced a partnership with Emory University’s Winship Cancer Institute on July 11, meaning the institute will use the company’s tools in its research.
Wellsheet. On July 17, Wellsheet, which uses AI to bolster clinical workflows and operations, launched an AI copilot embedded into existing electronic health records systems and designed to assist with chart summarization, discharges, and documentation.